Patent ID: 8642067
Filing Date: 2014-02-04
Classification: A61K,A61P

Abstract:
1. A method for treating an ocular condition, the method comprising: administering to the interior of an eye a composition comprising a therapeutically effective amount of a tyrosine kinase inhibitor to a mammal suffering from an ocular condition, wherein the composition also comprises i) a viscosity inducing component in an amount effective to increase the viscosity of the composition to a viscosity at about 25° C. of at least about 70,000 cps at a shear rate of about 0.1/second, and ii) a resuspension component, wherein said viscosity inducing component is injectable into the vitreous of a mammalian eye without permanently diminishing visual acuity, and wherein said resuspension component is selected from the group consisting of Vitamin E tocopheryl polyethylene glycol succinates, Vitamin E tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), Vitamin E tocopheryl polyethylene glycol succinamides, and Vitamin E tocopheryl polyethylene glycol 1000 succinamide (Vitamin E TPGSA).